Announcement on Voluntary Disclosure of Completion of Inclusion of the First Subject in Phase Ⅲ Clinical Trial of Litasert Eye Drops

About this update from Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class A

Announcement on Voluntary Disclosure of Completion of Inclusion of the First Subject in Phase Ⅲ Clinical Trial of Litasert Eye DropsThe abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class A